Pharma Mar SA (PHMMF)
106.48
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Pharma Mar Total Assets (Quarterly) : 443.90M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 443.90M |
| December 31, 2025 | 465.12M |
| September 30, 2025 | 401.45M |
| June 30, 2025 | 408.79M |
| March 31, 2025 | 360.24M |
| December 31, 2024 | 362.50M |
| September 30, 2024 | 371.79M |
| June 30, 2024 | 339.85M |
| March 31, 2024 | 360.62M |
| December 31, 2023 | 376.93M |
| September 30, 2023 | 369.94M |
| June 30, 2023 | 391.33M |
| March 31, 2023 | 406.02M |
| December 31, 2022 | 420.21M |
| September 30, 2022 | |
| June 30, 2022 | 408.53M |
| March 31, 2022 | 420.61M |
| December 31, 2021 | 419.47M |
| September 30, 2021 | 402.96M |
| June 30, 2021 | 406.22M |
| March 31, 2021 | 405.60M |
| December 31, 2020 | 404.09M |
| September 30, 2020 | 386.66M |
| June 30, 2020 | 395.60M |
| March 31, 2020 | 302.41M |
| Date | Value |
|---|---|
| December 31, 2019 | 139.98M |
| September 30, 2019 | 122.69M |
| June 30, 2019 | 147.75M |
| March 31, 2019 | 186.51M |
| December 31, 2018 | 180.25M |
| September 30, 2018 | 203.09M |
| June 30, 2018 | 222.56M |
| March 31, 2018 | 228.32M |
| December 31, 2017 | 225.41M |
| September 30, 2017 | 239.64M |
| June 30, 2017 | 253.42M |
| March 31, 2017 | 231.71M |
| December 31, 2016 | 239.39M |
| September 30, 2016 | 235.46M |
| June 30, 2016 | 245.00M |
| March 31, 2016 | 248.41M |
| December 31, 2015 | 236.51M |
| September 30, 2015 | 274.25M |
| June 30, 2015 | 248.59M |
| March 31, 2015 | 221.00M |
| December 31, 2014 | 243.69M |
| September 30, 2014 | 269.78M |
| June 30, 2014 | 301.27M |
| March 31, 2014 | 282.82M |
| December 31, 2013 | 260.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oryzon Genomics SA | 163.27M |
| Grifols SA | 23.13B |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alkermes Plc | 4.258B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 155.18M |
| Shareholders Equity (Quarterly) | 287.67M |
| Debt to Equity Ratio | 0.1904 |
| Current Ratio | 3.065 |
| Net Debt Paydown Yield | -0.03% |